TransMedics Group

TMDXNasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$3.054 B

$88.07 +0.89%

Close of 22 Sept 2026

Revenue

$605.5M

#1813 by revenue

Earnings

$190.3M

#1023 by earnings

Shares outstanding

34,675,145

Latest filing cover page

P/E ratio

16.0

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 28 →

#2LivaNovaLIVN$4.32B
#3IntegerITGR$4.29B
#4TransMedics GroupTMDX$3.05B
#5AxogenAXGN$2.61B
#6Biolife SolutionsBLFS$1.86B

Insiders buying

All insider buying →

One open-market purchase by officers and directors of TransMedics Group, worth $109.1K. Grants and option exercises are excluded.

David Weill$109.1K
1,336 shares at $81.63 on 11 Sept 2026 · filed 14 Sept 2026

What if TransMedics Group were worth as much as…

Open the what-if tool →

Gold $30.2T

$871,920.50

Per share 9,900× higher

Bitcoin $1.74T

$50,227.77

Per share 570× higher

Nvidia $5.52T

$159,069.76

Per share 1,806× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for TransMedics Group are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.